- About
-
The Global ETD Search service is a free service for researchers
to find electronic theses and dissertations. This service is
provided by the
Networked Digital Library of Theses and Dissertations.
Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
Search results
Showing 21 to 26 of 26 (0.033 seconds)| 21 |
PPARγ and Smad2 Mediate Ski Induced Energy Metabolism Shift and Oncogenic TransformationYe, Fang January 2010 (has links)
No description available.
|
| 22 |
Molecular mechanisms of myofibroblast differentiation and the role of TGF beta 1, TNF alpha, and thrombin signal transductionLiu, Xiaoying 31 August 2009 (has links)
No description available.
|
| 23 |
Efeito da Quimiocina CXCL10 na infecÃÃo por Leishmania infantum/chagasi em camundongos BALB/C / Effect of chemokine CXCL10 in Leishmania infantum chagasi infection in BALB/c mice.Webertty Mayk EufrÃsio de Figueiredo 17 February 2012 (has links)
A leishmaniose visceral causada por Leishmania infantum chagasi à caracterizada pela perda da habilidade do hospedeiro gerar uma resposta imunolÃgica eficaz. Neste estudo, foi investigado o papel da quimiocina CXCL10 no controle da infecÃÃo por L. infantum chagasi in vivo. Grupos de camundongos BALB/c foram tratados ou nÃo com CXCL10 (5 μg/kg) com 1, 3 e 7 dias de infecÃÃo e apÃs 1, 7 e 23 dias do tratamento, alguns parÃmetros foram avaliados: a carga parasitÃria, os nÃveis de IFN-, IL-4, TGF-β e IL-10, e as alteraÃÃes histopatolÃgicas no fÃgado. ApÃs 23 dias de tratamento, CXCL10 induziu, no baÃo, uma reduÃÃo expressiva no nÃmero de parasitos, quando comparado ao grupo controle. No fÃgado, a carga parasitÃria mostrou uma queda no grupo tratado, entre o 7 e 23 dia apÃs o tratamento. Entretanto, o efeito leishmanicida de CXCL10, neste trabalho, nÃo parece ser mediado por NO, uma vez que nÃo houve diferenÃa na produÃÃo de NO entre os grupos. IFN-γ foi induzida de maneira mais significativa no grupo tratado do que nos controles, e atingiu sua produÃÃo mÃxima (100 pg/mL) no 23 dia apÃs o tratamento, correlacionando-se com a queda da carga parasitÃria nos ÃrgÃos-alvo. IL-4 foi produzida em baixas concentraÃÃes, em ambos os grupos, embora os animais tratados com CXCL10 tenham mostrado nÃveis mais elevados do que os controles. Em relaÃÃo Ãs citocinas antiinflamatÃrias, apÃs 23 dias do tratamento, os nÃveis de IL-10 nos animais tratados foram menores do que os do controle. A produÃÃo de TGF-β apÃs 7 dias do tratamento foi 2 vezes menor no grupo tratado quando comparado ao controle, e apÃs 23 dias do tratamento, essa citocina continuou com nÃveis mais baixos do que aqueles observados no controle. Na anÃlise histopatolÃgica do fÃgado apÃs o 1 dia do tratamento, foram encontrados, em ambos os grupos, mais granulomas imaturos (GI), do que infiltrados nÃo granulomatosos (NG) e alguns poucos granulomas maduros (GM) apenas no grupo tratado. ApÃs 7 dias do tratamento, a quantidade de infiltrados NG estava menor e os GI ainda foram os mais encontrados, em ambos os grupos, alÃm disso, foi observado um pequeno aumento de GM no grupo tratado. Em resumo, diante dos resultados encontrados, à possÃvel sugerir um importante papel leishmanicida de CXCL10 em camundongos BALB/c infectados por L. infantum chagasi, que parece ser mediado por uma expressiva produÃÃo de IFN-g e supressÃo das citocinas imunorreguladoras, IL-10 e TGF-β, abrindo a hipÃtese se isto nÃo estaria associado a uma diminuiÃÃo na frequÃncia de cÃlulas T regulatÃrias, induzida por CXCL10, nesses animais. / Visceral leishmaniasis caused by Leishmania infantum chagasi is characterized by the loss of the ability of host to generate an effective immune response. In this study it was investigated the role of CXCL10 chemokine in controlling L. infantum chagasi infection in vivo. Groups of BALB/c mice were treated or not with recombinant CXCL10 chemokine (5 μg/kg) with 1, 3 and 7 days of infection and after 1, 7 and 23 days of treatment, some parameters were evaluated: parasite load, levels of IFN-g, IL-4, TGF-β and IL-10, and the histopathological alterations in the liver. After 23 days of treatment, CXCL10 induced in the spleen a significant reduction on the number of parasites as compared to control group. In the liver, parasite load decreased in treated group between the 7th and 23th day post treatment. However, the antileishmanial effect of CXCL10, in this work, does not seem to be mediated by NO, since there was no difference in the NO production among the groups. IFN-γ was induced most significantly in treated group than in controls, and reached its maximum production (100 pg/mL) on day 23 after treatment, correlating with the reduction in parasite burden in target organs. IL-4 was produced in low doses, in both groups, although treated animals had shown higher levels than control group. Regarding to anti-inflammatory cytokines, after the 23th day of treatment, IL-10 levels in treated animals were smaller than in control group. Production of TGF-β after 7 days of treatment was 2 times lower in treated group when compared to control, and after the 23th day of treatment, this cytokine remained with lower levels than those observed in control. In the histopathological analysis of the liver after the 1st day of treatment, were found in both groups more immature granulomas (GI) than non-granulomatous infiltrate (NG), and some few mature granulomas (GM) were only observed in treated group. After 7 days of treatment, the amount of NG infiltrates was lower, and GI were still the most frequent in both groups, besides a slight increase of GM was observed in treated group. In summary, at the light of the found results, it is possible to suggest an important leishmanicidal role to CXCL10 in BALB/c mice infected by L. infantum chagasi, which seems to be mediated by a significant IFN-g production, and suppression of immunoregulatory cytokines, IL-10 and TGF-β, opening the hypothesis that this would be associated to a decrease in the frequency of regulatory T cells induced by CXCL10 in these animals.
|
| 24 |
Somatic Acquisition of TGFBR1*6A in Cervical CancerTieche, Sarah Marie 08 December 2008 (has links)
No description available.
|
| 25 |
The requirement of Smad4 in Mouse Early Embryonic DevelopmentGuo, Jiami 26 July 2012 (has links)
No description available.
|
| 26 |
Role of Ring1B in ephitelial to mesenchimal transition, invasion and migration of mammary epithelial cellsBosch Gutiérrez, Almudena 21 December 2009 (has links)
The Polycomb group (PcG) family of proteins form chromatin-modifying complexes essential for embryonic development, and stem cell renewal and are commonly deregulated in cancer. There are several reports that address the possible implication of PcG proteins in tumor progression and metastasis, but very little is known about the specific role of these proteins in tumor progression and invasion. On the other hand, the molecular processes of the worst cancer prognosis, metastasis, which leads to an incurable disease, are yet incompletely elucidated. Here we show a role for Ring1B, a PcG protein, in three processes related to metastasis: in the Epithelial-mesenchymal transition (EMT), a critical morphogenic event that occurs during embryonic development and during the progression of various epithelial tumors, an in the migration and the invasion of mammary epithelial cells. / Las proteínas del grupo Polycomb (PcG) forman complejos modificadores de la cromatina esenciales en el desarrollo embrionario y en la renovación de las células madre, y su desregulación ha sido asociada al cáncer. Varios estudios muestran la posible implicación de las proteínas de PcG en la progresión tumoral y en la metástasis, pero a pesar de ello se sabe muy poco de los procesos moleculares en los que estas proteínas están participando. Por otro lado, los procesos moleculares responsables del peor pronóstico en cáncer, la metástasis, que continua siendo una enfermedad incurable, siguen sin estar completamente elucidados. En esta disertación mostramos el papel de Ring1B, una proteína del PcG, en tres procesos implicados en la metástasis: en la transición epitelio-mesénquima (EMT), un proceso morfogénico crítico en el desarrollo embrionario y durante la progresión de varios cánceres epiteliales, y en la migración y la invasión de las células epiteliales mamarias.
|
Page generated in 0.0403 seconds